05 January 2023
: Case report 
Immune-Mediated Adverse Drug Reactions (IM-ARDs) in the Form of Drug-Induced Immune Thrombocytopenia and Cutaneous Adverse Drug Reactions (CARD) Due to Clindamycin in an Human Immunodeficieny Virus (HIV) Patient
Unknown etiology, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)
Nata Pratama Hardjo Lugito
1ABCDEF*, Andree Kurniawan 1CDF, Nana Novia Jayadi2CDF, Erna Kristiani3CDF
DOI: 10.12659/AJCR.938358
Am J Case Rep 2023; 24:e938358
Figure 2. Development of skin lesions. (A, B) Day 1. There were generalized erythematous macules and papules, with palpable petechia and purpura. There were no lesions in the mouth, eyes, or genitalia. (C) Day 2. (D) Day 3. (E) Day 6. (F) Day 7. (G) Day 10. (H) Day 15. The generalized erythematous macules became hyperpigmented, and there were fewer petechia and purpura. (I) Day 30. There were only hyperpigmented patches on the skin, and the petechia and purpura had resolved.